Sidebar is Loading...
Loading...
Brands
Resources
YSTV
ADVERTISEMENT
Loading...
Brands
Resources
YSTV
Alixir is working on the mammographic detection system of the future.
Headquartered in Sydney, Australia, Alixir is working on the mammographic detection system of the future, combining instant reporting with accuracy that exceeds a radiologist. Alixir uses deep learning to segment and classify potential cancerous lesions on mammograms, leading to earlier detection and better patient outcomes. Our cloud infrastructure can easily integrate with PACS / BIS systems and enable scalable reporting on demand. Their Salient Features: More Accurate - Early studies of Alixir's breast cancer screening system have shown a sensitivity of over 95% and a specificity of 93% on a well-established segmented test set for digital mammography; Faster - Alixir can segment a digital mammogram and provide customised reporting in seconds, expediting necessary call-backs and saving lives; Cost Effective - Alixir can augment or replace a human read, making the screening process more accurate and more cost effective than ever before.
Headquarters
:
Sydney, New South Wales, Australia
Founding Date
:
2017
No. of Employees
:
<10
Core Team
:
1.
Benson Riddle
Co-Founder & CMO
2.
Joe Logan
Co-Founder & CTO
Investors
:
1.
Artesian VC
Frequently Asked Questions
